IP Verse

Mylan Pharmaceuticals Inc. et al. v. Regeneron Pharmaceuticals, Inc. - IPR2022-01225

Explore the PTAB proceeding IPR2022-01225 filed by Mylan Pharmaceuticals Inc. et al. against Regeneron Pharmaceuticals, Inc. on Jul 1, 2022. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2022-01225
Filing Date
Jul 1, 2022
Petitioner
Mylan Pharmaceuticals Inc. et al.
Respondent
Regeneron Pharmaceuticals, Inc.
Status
Final Written Decision
Respondent Application Number
15471506
Respondent Tech Center
1600
Respondent Patent Number
10130681
Institution Decision Date
Jan 11, 2023
Termination Date
Jan 9, 2024

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2022-01225.

TypeName
Petitioner CounselMolino, Paulet al
Respondent CounselFishman, Deborahet al

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.